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The 180-amino acid core of the TATA-binding protein 
(TBPcore) is conserved from Archae bacteria to man. 
Vertebrate TBPs contain, in addition, a large and highly 
conserved N-terminal region that is not found in other 
phyla. We have generated a line of mice in which the tbp 
allele is replaced with a version, tbpAN, which lacks 111 
of 135 N-terminal amino acid residues. Most tbpAN/AN' 
fetuses die in midgestation. To test whether a disruption 
of general cellular processes contributed to this fetal 
loss, primary fibroblast cultures were established from 
+/+, AN/+, and AN/AN fetuses. The cultures exhibited no 
genotype-dependent differences in proliferation or in 
expression of the proliferative markers dihydrofolate 
reductase (DHFR) mRNA (S phase-specific) and cdc25B 
mRNA (G2-specific). The mutation had no effect on tran­
scription initiation site fidelity by either RNA polymer­
ase II (pol II) or pol III. Moreover, the mutation did not 
cause differences in levels of U6 RNA, a pol III-depend- 
ent component of the splicing machinery, in mRNA 
splicing efficiency, in expression of housekeeping genes 
from either TATA-containing or TATA-Iess promoters, 
or in global gene expression. Our results indicated that 
general eukaryotic cell functions are unaffected by de­
letion of these vertebrate-specific sequences from TBP. 
Thus, all activities of this polypeptide domain must ei­
ther be compensated for by redundant activities or be 
restricted to situations that are not represented by pri­
mary fibroblasts.
Gene expression is a fundamental property of all living sys­
tems. Archae bacteria use only a single RNA pol1 to transcribe 
mRNA, rRNA, and tRNA. Eukaryotes evolved three separate 
RNA pols with different specialties to perform these functions.
* This work was supported by grants from the March of Dimes Foun­
dation, National Institutes of Health, National Science Foundation, and 
USDA Animal Health Funds (to E. E. S.) and by awards from the
Howard Hughes Medical Institute and the Mathers Charitable Foun­
dation (to M. R. C.). The costs of publication of this article were de­
frayed in part by the payment of page charges. This article must 
therefore be hereby marked “advertisement” in accordance with 18 
U.S.C. Section 1734 solely to indicate this fact.
§ Funded as a Basil O’Connor New Investigator of the March of 
Dimes Foundation, a Howard Hughes Medical Institute Fellow of the 
Life Sciences Research Foundation, and as an Investigator of the Mon­
tana Agricultural Experiment Station. To whom correspondence should 
be addressed. E-mail: eschmidt@montana.edu.
H Supported by a postdoctoral fellowship from the USDA and by an 
appointment in the laboratory of M. W. White.
1 The abbreviations used are: pol, polymerase; TBP, TATA-binding 
protein; MEF, mouse embryo fibroblast; RT, reverse transcriptase; 
SAGE, serial analysis of gene expression; EST, expressed sequence tag; 
g.d., gestational day; DHFR, dihydrofolate reductase; GAPDH, gl.ycer- 
aldehyde-3-phosphate dehydrogenase; TRF, TBP-related factor.
TBP acts in promoter recognition for transcription initiation by 
the Archaea RNA pol as well as by all three eukaryotic RNA 
pols (1—3). In accordance with having such an important and 
conserved function, the 180-amino acid TBPcore from Archaea 
and from all eukaryotes share both a high degree of amino acid 
similarity and very similar crystal structures (3-5).
The differences in complexity observed between Archaea and 
eukaryotes, or between single-celled and higher eukaryotes, 
are coincident with differences both in genomic complexity and 
in the complexity of the gene expression machinery. Similarly, 
although the general role of TBP in transcription initiation has 
been conserved, this function has become more complex. In 
Archaea TBP appears to work as a single-subunit entity (6); in 
eukaryotes TBP is at the core of obligate large multiprotein 
complexes (3). The complex SL1 functions in initiation by RNA 
pol I, TFIID is required for production of mRNA by RNA pol II, 
TFIIIB is used during transcription of tRNAs and some other 
small RNAs by RNA pol III. In mammals, TBP also interacts 
with SNAPc to direct production of small nuclear RNAs ( snR- 
NAs) by either pol II or pol III (3).
Attached to the TBPcore, vertebrate species share a large 
N-terminal domain that differs from TBP domains in all other 
phyla (3, 7-11). Previous studies have implicated the verte­
brate N terminus in general processes that are important for 
fundamental cellular activities. For example, biochemical anal­
yses have demonstrated a role of the vertebrate N terminus in 
the function of the SNAPc complex ( 3, 12-14). Kinetic studies 
indicate that the N-terminal domain influences TATA-binding 
and DNA-bending by TBP (15). Another study suggests that 
the N terminus plays a role in determining rates of cell prolif­
eration (16).
Because these fundamental cellular functions are common to 
most eukaryotes, including non-vertebrate metazoans, they 
evolved long before the vertebrate TBP N terminus.2 Therefore, 
we hypothesized that this domain must have, in addition to any 
general functions, a vertebrate-specific role. To test this, we 
created a line of mice in which the wild type tbp allele was 
replaced with a version, entitled ibpAN, in which 111 of the 135 
vertebrate-specific N-terminal amino acids were deleted (11). 
At gestational day (g.d.) 9.5, tbpAN/AN fetuses are generally 
normal (11). Over 90% of these mutant fetuses die between g.d. 
10.5 and 12.5; loss results from a failure of their placenta to 
evade a maternal immune rejection response (11). Importantly, 
although less than 3% of the tbpAN/AN animals survive to wean­
ing, these survivors are healthy and fertile (11).
Even though the defects in homozygous mutant mice are 
manifested as a highly specific and restricted phenotype, it is 
untested whether the mutation actually compromises general
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cell functions in a sublethal manner. For example, one might 
hypothesize that all cells bearing this mutation would be phys­
iologically compromised; however, only in the placenta are such 
defects critical to the function of the organ and the survival of 
the organism. To test this possibility, we analyzed fundamental 
properties of cells bearing this mutation. We show that tbpAN/ h 
and tbpAN/AN primary mouse embryo fibroblasts (MEFs) are 
normal in all measured general functions. Our data indicate 
that, if the TBP N terminus truly participates in any funda­
mental functions in vivo, these processes must be functionally 
redundant.
EXPERIMENTAL PROCEDURES
Mouse and MEF Production—The targeting and mouse production 
strategy for producing the TBP-AN mice has been reported elsewhere 
(tt). The selectable neo cassette used for gene targeting was removed 
from the line by Cre/loxP, and for all samples in this article, the 
mutation had been back-crossed onto a C57B1/6 background for &5 
generations (tt). For establishing primary fibroblast cell lines, whole 
uteri were harvested from females with timed pregnancies and were 
surface-sterilized with 70% ethanol. Deciduae were opened and embry­
onic surface tissue was harvested and dissociated with trypsin. Ex­
planted cells were cultured in Dulbecco’s modified Eagle’s medium + 
10% newborn calf serum + tx penicillin/streptomycin/fungizone (Bio- 
Whittaker). Cultures were trypsinized and passed to fresh dishes when 
confluent, after 5-14 days. By this time under these conditions, fibro­
blasts had outgrown other surviving cell types to the point that only 
cells with fibroblastic morphology could be readily found under the 
microscope. These cultures were split in experiments.
RNase Protection, RT-PCR, and Primer Extension Assays—RNA har­
vests and RNase protection and primer extension assays were pre­
formed as described previously (18, 19). Probes for DHFR (18), TFIIB, 
L7, GAPDH, Oct-1, and NF-Yb (19) have been described previously. For 
TBP-related factor-2 (TRF-2), a probe hybridizingto sequences between 
positions 705 and 833 of the mouse TRF-2 cDNA (20) was transcribed 
from a clone that we isolated by RT-PCR on mouse testis RNA.a A probe 
that hybridized to mouse U6 RNA sequences extending from the tran­
scription initiation site to a position 92 bases downstream of the initi­
ation site (21) was transcribed from a genomic clone that we isolated by 
PCR of mouse genomic DNA.1’ For f!-actin, mouse genomic sequence was 
not available. A mouse genomic fragments extending from a position in 
exon 2 corresponding to base 89 of the mouse cDNA (22) to a position 51 
base pairs into intron 2, was amplified from mouse genomic DNA using 
one primer designed from mouse exon 2, and a second primer designed 
from the genomic sequence of rat intron 2 (23), and this fragment was 
cloned into a plasmid vector. The f!-actin probe hybridizes to 146 bases 
of the mouse pre-mRNA and 95 bases of the mouse mRNA (Fig. 3 B). For 
TBP, a probe that was complementary to sequences extending from the 
BglW site in exon 2 (position 37 of the original published cDNA se­
quence) to position 168 in exon 3 (24) was transcribed from a subclone 
of the mouse TBP cDNA. This probe hybridized to 131 bases of wild-type 
TBP mRNA, and 81 bases of TBP-AN mRNA (Fig. IB). For primer 
extensions, the following primers were used: U6 primer, 5'-ATC GAA 
TTC ACG AAT TTG CTG GTC ATC C-3'; f!-actin primer, 5'-TGG GGT 
ACT TCA GGG TCA GGA TAC-3'.
For RT-PCR reactions, 2.5 /ng of CsCl-purified DNA-free RNA (19) 
was used as template for oligo(dT)-primed reverse transcriptase reac­
tions as described previously (25). PCR with primers spanning from 
exon 2 to exon 3 of the mouse f!-actin gene confirmed that all cDNAs had 
uniform levels of f!-actin cDNA and lacked detectable genomic DNA 
(data not shown). PCR was performed using 0.2% of each RT reaction 
per PCR reaction, as described in the figure legends, using mouse 
cdc25B-specific primers having the following sequences: 5' primer, 5'- 
ATT CCA GCT CTG CCC AAG CTT TGG C-31; 31 primer, 5 -TCC ACA 
AAT CCG TCA TCT TCT TCA-3'. The PCR product spans from posi­
tions 626 to 821 of the mouse cdc25B mRNA (GenBank’1’1'1 XMJ123867; 
translation initiation is at position 607), which contains a centrally 
located splice junction for a 621-base pair intron at position 712 (Gen­
Bank™ NW_000178). Thus, genomic DNA gives a 816-base pair band 
that is clearly discernablefrom the 195-base paircDNA signal (data not 
shown).
Serial Analysis of Gene Expression (SAGE)—SAGE libraries were 
prepared as described previously (26). Clones of individual plasmids
J E. E. Schmidt, unpublished data.
containing SAGE tag concatenates were screened by PCR and clones 
containing inserts of >500 bp (roughly 30 SAGE tags) were arbitrarily 
chosen for sequence analysis. Data were ordered by SAGE2000 soft­
ware (www.sagenet.org). Data in the article represent all tags that 
appeared >10 times in the combined libraries and represent all 46 
genes present at an average of >1.5 parts per thousand. Summation 
of tag frequencies indicated that 77% of all tags sequenced were 
represented by these 46. The identities of mRNAs represented by 
individual tags was determined using the tag-to-gene mapper program 
on the NCBI SAGEmap homepage (www.ncbi.nlm.nih.gov/SAGE/ 
SAGEtag.cgi).
RESULTS
mRNA and Protein Expression from the tbpAN Allele—The 
tbpAN allele retains all known transcriptional and post-tran­
scriptional regulatory signals of the wild-type tbp allele (25, 27, 
28), but it produces a version of TBP protein lacking 111 of 135 
vertebrate-specific N-tenninal amino acids (Fig. 1A, described 
in Ref. 11). Retention of the first 24 amino acids was predicted 
to preserve the in vivo stability of the mutant protein (11, 29). 
Thus, the allele is identical to the native tbp allele except that 
it encodes an epitope tag in place of amino acids 25^ 135 of the 
protein, and it contains a ZoxP-containing oligonucleotide in­
sertion roughly 2.5-kb upstream of the gene (11).
To investigate the molecular consequences of removing the N 
terminus of TBP on basal cellular functions, we produced pri­
mary MEFs from g.d. 8.5—11.5 embryos. RNase protection as­
says using a probe that spanned the site of the AN mutation 
were used to compare levels of wild-type and mutant TBP 
mRNA accumulation in tbp h/h, tbpAN/ \  and tbpAN/DN MEFs. 
Results showed that homozygous wild-type and homozygous 
mutant cells had similar levels of TBP or TBP-AN mRNA, 
respectively, and, in heterozygous cells, mRNA from each allele 
was equally represented (Fig. IB). Western blots using either 
whole cell (Fig. 1C) or nuclear (data not shown) extracts indi­
cated that MEFs of all three genotypes contained similar levels 
of total and nuclear TBP and TBP-AN protein; heterozygous 
MEFs exhibited similar amounts of both TBP and TBP-AN 
protein. Based on mRNA level, protein level, and subcellular 
distribution, TBP and TBP-AN proteins had no significant dif­
ferences in synthesis/turnover rates or nuclear localization.
Previously, a mammalian tbp-gene family member, named 
TBP-like protein (TLP) (30) or TRF-2 (31, 32) was identified. 
The TRF-2core is far less closely related to the homologous 
region of mouse TBP (39% amino acid identity) than mouse 
TBPcore is to yeast TBPcore (81% identity; Fig. 2, Ref. 30). 
Different annotations of the human genome suggest that this 
may be the only other tbp family member in mammals (33) or 
that there may be one other more distantly related protein in 
the genome (34). We measured TRF-2 mRNA levels in adult 
mouse tissues and in MEFs of all three genotypes. Results 
showed that TRF-2 mRNA is expressed in wild-type MEFs (Fig. 
2). TRF-2 was also expressed in all wild-type somatic mouse 
tissues examined at levels about 4-fold higher than those of 
TBP mRNA in each tissue and, consistent with previously 
published reports (32), TRF-2 mRNA was particularly enriched 
in testis. TRF-2 mRNA levels were unaffected by the TBP-AN 
mutation in both the MEFs and in adult tissues (Fig. 2). Be­
cause TRF-2 contains only a short N-tenninal region fused to 
the core (30), we consider it highly unlikely that TRF-2 com­
pensated for deletion of the N-tenninal region of TBP in 
tbpAN/AN fibroblasts or mice.
Basal Properties of Cells Lacking the TBP N Terminus— 
Because we have shown that tbpAN/AN mutant animals occa­
sionally survive to become healthy fertile adults (11), it is 
unlikely that large global defects result from the mutation. 
However, previous studies had implicated this domain in basal 




























Fig. 1. Primary structure and expression of TBP and TBP-AN 
in MEFs. A. alignment of wild-type TBP and TBP-AN. showing the 
universal C terminus (black box) and the vertebrate-specific N terminns 
(white box). The mutant version retains amino acids 1-24 and 136-316 
of the wild-tvpe allele, and contains two copies of the 9-amino acid 
FLAG (Kodak) epitope tag (grav box labeled E) (11). B. expression of 
TBP mRNA in MEFs. Total RNA (10 ftg) from two cultures each of 
tbp'n . tbp^ Nn . and tbpAA"-W MEFs was analyzed by RNase protection 
using a probe that differentiates between wild-type and mutant TBP 
mRNA. All samples were supplemented to contain a total of 50 /iig of 
RNA with yeast RNA. MEF genotypes are indicated at top. At right is 
indicated the positions of undigested probe and of the protected frag­
ments for wild-type (TBP1) and mutant (TBPAN) mRNA. Abbreviations: 
M. molecular size markers; P. 1:100 dilution of undigested probe; C. 
control containing probe hybridized to 50 /iig of yeast RNA. C. Western 
blot of TBP and TBP-AN protein expression in MEFs. Whole cells of the 
indicated genotypes were harvested by scraping in 1% SDS. and lysates 
were sonicated and boiled. Nucleic acid content was estimated by read­
ing the Am0 on each lysate, and 20 /iig of nucleic acid equivalents was 
boiled with an equal volume of Laemmli buffer for each determination 
(17). Western blots were probed with commercial antibody against the 
C-terminal domain of human TBP (BD PharMingen). which shows 
100% amino acid identity with this region of mouse TBP and was 
visualized by ECL (Amersham Biosciences).
whether, rather than only functioning in a particular situation 
(pregnancy), the N terminus functioned ubiquitously, but de­
fects resulting from its deletion were sublethal in most cell 
types. Therefore, we tested whether defects in basal functions 
could be detected in cells bearing the TBP-AN mutation.
We first asked whether we could measure defects in SNAPc- 
dependent processes. In mammals, SNAPc is involved in tran­
scription initiation on genes encoding snRNAs by pol III from 
TATA-containing promoters, and by pol II from TATA-less 
promoters (3). A classic example is its role in transcription of 
the human U2 gene by RNA pol II, and the U6 gene by pol III 
(35). RNase protection assays showed that U6 RNA levels in
Fig. 2. Mouse TRF-2 expression in MEFs. At top is diagramed the 
primary structure and the C-terminal (shaded regions) amino acid 
conservation between yeast TBP (yTBP), mouse TBP (mTBP), and 
mTRF-2. Beloio is an RNase protection assay on dilutions of total RNA 
from wild-type mouse testis (10. 3.0. 1.0. 0.3. 0.1. and 0.03 /iigfrom left 
to right), and on 20 /iig each of total RNA from wild-type mouse kidney 
and from MEFs of the indicated genotypes. All samples were supple­
mented to 50 /iig with yeast RNA. The TRF-2-specific RNase protection 
fragment is indicated at the right. Abbreviations as in the legend to 
Fig. 1.
MEFs of the three genotypes were indistinguishable (Fig. 3A).
Splicing requires an elaborate ribonucleoprotein system 
that, in addition to U6 and U2, requires other snRNAs (36^ 39). 
As a potentially more global assay for whether any defects in 
snRNA expression resulted from the TBP-AN mutation, we 
examined the splicing efficiency of pre-mRNA encoding j3-actin 
by RNase protection ( Fig. 3B). Levels of correctly spliced cyto­
plasmic mRNA (95-base band) were unaffected by the muta­
tion, and there was no evidence for increased nuclear accumu­
lation of unspliced pre-mRNA (146-base band in lanes 
designated Nu). This indicated that splicing efficiency was 
similar between MEFs of the three genotypes. We concluded 
that deletion of TBP amino acids 25^ 135 was inconsequential 
for U6 RNA expression and mRNA splicing in the MEFs. Pre­
vious studies have shown that the first 55 amino acids of 
human TBP are sufficient for SNAPc functions in vitro, includ­
ing U6 transcription (40). These data, in combination with our 
results, might suggest that SNAPc-dependent functions of 
the TBP N terminus reside entirely in the first 24 amino 
acids of the protein. Alternatively, it is possible that other 
compensatory interactions at the snRNA promoters stabilize 
SNAPc interactions in cells lacking the TBP N terminus (see 
“Discussion”).
In one study, chicken DT40 cells that were heterozygous-null 
for TBP were shown to have lower proliferation rates than did 
the wild-type progenitor cell line, which correlates to reduced 
levels of mRNA and protein encoding cdc25B (16). Upon stably 
transfecting these cells with vectors that express wild-type 
TBP, proliferation rates match the progenitor cells. However, 
clones transfected with vectors that express a mutant version 



























Fig. 3. Expression of U6 RNA and splicing efficiency in MEFs.
A, U6 RNA expression. 5 /ng of total RNA from MEFs of the indicated 
genotypes was supplemented to 50 /ng with yeast RNA and assayed by 
RNase protection. The positions of undigested probe and U6 RNA are 
indicated at left. B, £>-aetin pre-mRNA splicing efficiency. At top is 
diagrammed the single-probe internally controlled RNase protection 
strategy for differentiating prespliced and spliced -^actin RNA. 5 /ng 
each of cytoplasmic (C'.y) and nuclear (Nuj RNA was supplemented to 50 
jiig with yeast RNA as above. The positions of undigested probe, un­
spliced pre-mRNA and spliced mRNA are indicated at the left. Abbre­
viations as in the legend to Fig. t.
terminus exhibit an intermediate proliferation rate (16). These 
results suggest that the N terminus is required for full prolif­
erative potential of the cells. Importantly, all of the cells in the 
study by Um et al. (16) contained one intact copy of the endog­
enous tbp gene including the entire N-terminal region, and 
thus, the anti-proliferative effect was manifested as a 
haploid-insufficiency.
We established MEF cultures from 139 embryos of heterozy­
gous crosses, but we were unable to detect any significant 
correlation between genotypes and proliferation rates by either 
growth curves or thymidine labeling (data not shown). Even in 
comparing homozygous mutant cells, where both copies of tbp
Fig. 4. Expression of proliferative cell markers in MEFs and in 
tissues. A, DHFR mRNA expression. 30 jiig of total RNA from MEFs of 
the indicated genotypes was supplemented with yeast RNA to 50 /ng 
and assayed by RNase protection using the DHFR-specific probe. B, 
cdc25B mRNA expression. Total RNA from four independent cultures 
each of wild-type (tbp'1'), heterozygous (tbp^'j, and homozygous 
mutant (f6piiVMiv) MEFs, two individual g.d. 10.5 whole fetuses of each 
genotype, and one g.d. 10.5 whole placenta of each genotype (indicated 
at left; 21 independent tissue/cell samples shown) was assayed by 
RT-PCR. Reactions were terminated at the indicated PCR cycles (top) to 
generate an expression curve for each, showing that the reactions were 
not saturated. The PCR product spans a 621-base pair intron. Only the 
195-base pair cDNA-derived sequence, not the 816-base genomic prod­
uct, was detected, which confirmed that samples were not contaminated 
by genomic DNA. Control reactions using primers that spanned from 
exon 2 to exon 3 of mouse £>-aetin showed equivalent signals from all 
samples (not shown).
lacked the N terminus, and homozygous wild-type cells, prolif­
eration rates were indistinguishable. As a potentially more 
sensitive molecular assay of proliferation, levels of the mRNA 
encoding DHFR, which is transcribed only during S-phase of 
the cell cycle (18, 41, 42), were measured. MEFs of all three 
genotypes exhibited similar levels of DHFR mRNA (Fig. 4A).
Previous studies have shown that cdc25B mRNA is ex­
pressed only during G2 phase of the cell cycle (43, 44) and that 
expression of this mRNA may be particularly sensitive to mu­
tations in the tbp gene (16). Therefore, as another molecular 
marker of proliferation rates, we compared relative cdc25B 
mRNA levels in tbp h/ h, tbpAN,\  and tbpAN,AN MEFs, as well as 
in g.d. 10.5 fetuses and placentas of all three genotypes. Re­
sults showed that cdc25B mRNA levels were similar between 




























Fig. 5. Transcription initiation site fidelity in MEFs. Poly(A1 )- 
selected mRNA (panel A) or total RNA (panel B) was analyzed by 
primer-extension assays using either the |3-actin primer (the |3-actin 
gene is transcribed by pol II; panel A) or the U6 primer (the u6 gene is 
transcribed by pol III; panel B). Positions of free primers and primer 
extension products are indicated at the left of each panel.
otypes, and between placentas of all three genotypes (Fig. 4B). 
The genotype-independent reduced level of cdc25B mRNA in 
placentas as compared with those in MEFs and fetuses likely 
represents a lower overall rate of proliferation in this organ. 
These data suggest that the TBP N terminus does not play a 
significant role, either as a dominant (i.e. haploid-insufficient) 
or recessive trait, in determining proliferation rates in MEFs.
Transcription and RNA Processing in tbpAN,AN anc[ tbpAN/" 
Cells—Because our study examines a targeted mutation in a 
fundamental component of the basal transcription machinery 
in vivo, we examined whether the mutation had measurable 
effects on initiation site fidelity or RNA accumulation. Tran­
scription initiation site fidelity was assessed by primer exten­
sion assays on MEFs of all three genotypes. Results indicated 
that our mutation had no quantitative or qualitative effects on 
initiation site fidelity of RNAs transcribed by either pol II 
( j3-actin mRNA) or by pol III (U6 RNAXFig. 5).
Although TBP, TRF-2, U6, j3-actin, DHFR, and cdc25B 
mRNA levels were unaffected by the AN mutation (Figs. 1-5), 
we wished to determine whether there were effects on a 
broader range of mRNAs. Two additional highly abundant 
housekeeping mRNAs from genes with TATA-containing pro­
moters, encoding ribosomal protein L7 and GAPDH, and three 
low abundance housekeeping mRNAs from TATA-less promot­
ers, encoding TFIIB, Oct-1, and NF-Yb, were chosen for indi­
vidual analysis (45-47). Expression of all of these mRNAs were 
unaffected by the TBP mutation (Fig. 6A). As an unbiased 
representation of global gene expression, we used SAGE to 
estimate the relative abundance of all mRNAs in a sample 
based on the frequency that unique 3'-end sequence tags are 
present in a cDNA library made from that mRNA sample (26). 
SAGE libraries were created from +/+ and AN/AN MEFs and 
we sequenced 6890 tags, giving resolution of all mRNAs pres­
ent at >1.5 parts per thousand in each sample ( 77% of all of the 
mRNA in the cells; Fig. 6B). The SAGE data were externally 
corroborated because two of the tags, nos. 21 and 22, repre­
sented mRNAs that we had independently assayed by quanti­
tative RNase protection and primer extension assays (j3-actin, 
Fig. 3B, and GAPDH, Fig. 6A, respectively). None of the abun­
dant tags showed a strong effect of the mutation ( > 10-fold 
difference between cell types, dark shaded zones in Fig. 6B) and 
only three differed by 3-fold or more (light shaded zones). These 
three mRNAs may have been differentially regulated as a 
direct consequence of our mutation; however, they may also 
have simply represented stochastic differences between the cell 
lines that were independent of the TBP mutation. Further 
study will be required to distinguish these possibilities. Impor­
tantly, the data indicated that overall gene expression was not 
different in the two cell lines. We conclude that the TBP-AN 
mutation does not affect basal gene expression, and we infer 
that any gene expression defects arising from this mutation 
must be highly cell type- and/or gene-specific.
DISCUSSION
TBP is required by all eukaryotes for gene expression as well 
as for production of ribosomal RNAs and small RNAs. Consist­
ent with this, the core of this protein is one of the most highly 
conserved proteins known. However, outside of this core, on the 
N-terminal side of the protein, different phylogenetic lineages 
exhibit vastly different embellishments ( 3). To test the function 
of the vertebrate-specific TBP N terminus, we developed a line 
of mice in which these sequences had been largely deleted (11). 
In this article, we show that this mutation had no measurable 
effects on basal functions in cultured primary fibroblasts.
Previous biochemical and cellular studies on the function of 
the vertebrate-specific TBP N terminus have shown that this 
polypeptide domain has strong effects on DNA binding by TBP 
(15), on how TBP interacts with SNAPc and with certain tran­
scription factors (13, 14, 48-50), and on the function of TBP in 
transcribing genes encoding RNA components of the splicing 
machinery (14, 50). In addition, one study has shown that the 
TBP N terminus can affect rates of cell proliferation (16). By 
contrast, we show that MEFs lacking most of the TBP N ter­
minus show no general defects in transcription, splicing, gene 
expression, or proliferation. Results presented here, indicating 
that removing most of the TBP N terminus has no basal phys­
iological effects on fibroblasts, are corroborated by the obser­
vation that, even though few tbp mice survive to weaning,
survivors are healthy and fertile (11). Moreover, physiological 
processes that depend on proliferation are unaffected in survi­
vors. For example, homozygous mutant fetuses grow and de­
velop at normal rates in immune-compromised mothers (11), 
and homozygous mutant adults are normal size, they exhibit 
normal peripheral blood leukocyte counts, normal hair growth, 
and normal male fertility even after over a year of continuous 
mating (data not shown). What might be the reasons that our 
in vivo results on TBP-AN mutant mice do not show defects in 
any of the processes in which this domain has been implicated 
by in vitro studies?
One interesting property of living systems is that they are 
robust. In other words, they generally tolerate or rebound from 
perturbations of the system. Genetic studies and modeling 
experiments indicate that robustness can be accomplished by 
having parallel pathways that can independently accomplish 
the same task (51, 52). Conversely, fragments of biological 
systems, such as purified in vitro reactions, are generally op­
timized for a single reaction, and are relatively intolerant of 
perturbations. One might consider the possibility that the N 
terminus of TBP functions in a robust system. As examples, 
transcription factor Oct-1 may stabilize SNAPc on snRNA pro­
moters (50) in the absence of the TBP N terminus, and the 
ability of the N terminus to affect DNA binding by the TBPcore 
(15) may be partially redundant with activities of other pro­


























Fig. 6. Global gene expression. A, expression of selected housekeeping genes. RNase protection assays for the niRNAs indicated at the right 
were performed on total RNA from MEFs of the indicated genotypes as described in previous figures. B, expression of abundant mRNAs. SAGE 
was performed on libraries from +/+ and AN/AN MEFs at a resolution of 1.5 parts per 1000. Data are presented for the most abundant 46 tags. 
The top panel shows the relative expression profiles presented as fold-difference between the two cell lines, where up-regulation (positive values) 
are tags that are more abundant in the mutant than in wild-type MEFs, and down-regulation (negative values) are less abundant in the mutants. 
The bottom panel shows the abundance of each tag in both libraries combined, presented as parts per thousand. After exclusion of redundant 
di-tags, summation of all iterations of the 46 most abundant tags indicates that, of the 6890 tags in this analysis, 5872 (77%) were one of these 
46. Tag frequencies for representative mRNAs, indicated by their numerical designation on the bar graphs, are as follows: tag 5, ribosomal S28 
subunit; tag 7, ribosomal L23 subunit; tag tt, ferritin light chain mRNA; tag 13, ribosomal L36 subunit; tag 15, EST Mm.108736; tag 21, £>-actin; 
tag 22, GAPDH; tag 24, EST Mm.154997; tag 28, ribosomal L28a subunit; tag 30, eTEFl«; tag 32, HMG box-2 protein mRNA; tag 34, EST 
Mm.194288; tag 45, cytochrome c.
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may be compensated for by the other back-up proteins. One 
might envisage a model where the transcriptional assembly at 
a promoter forms a three-dimensional jigsaw puzzle that does 
not necessarily fall apart or lose activity as a result of removing 
this single piece. By such a model, cells lacking the TBP N 
terminus may be physiologically normal, but might also be 
more prone to failure in the event that the back-up system fails.
The previous study showing a role for the TBP N terminus in 
cell proliferation (16) is harder to reconcile with our data be­
cause that study, like ours, was performed in living cells. Dif­
ferences in experimental design are likely responsible for the 
different results. For example, whereas both studies required 
several generations of in vitro culture to generate a line of cells 
bearing the respective targeted mutations, cells in our study 
were rejuvenated by turning them into viable mice, breeding 
the mutant animals, and then harvesting our experimental 
cells as primary cultures from the resultant fetuses. Moreover, 
all modified tbp alleles in our study were within the normal tbp 
locus, and none of our cells contained selectable marker genes 
or vector sequences that might have affected mutant cells (11). 
Conversely, event though the tbp-null allele in the study by Um 
et al. (16) was targeted into the tbp locus, it retained an ex­
pressed hygromycin resistance gene, and the rescuing expres­
sion cassettes were random insertions that brought with them 
vector sequences, including an expressed puromycin resistance 
gene. Our data strongly suggest that the N terminus of TBP 
can be deleted without measurably altering cell proliferation.
Vertebrate and non-vertebrate metazoans universally share 
the basal properties that have been attributed to the vertebrate
TBP N terminus in previous studies (see above). Thus, if this 
domain indeed participates in such fundamental processes in 
vivo, they are likely accomplished equally well by the N termini 
of nematodes, dipterans, lepidopterans, and echinoderms, even 
though the N terminus in each group shows neither similarity 
to the vertebrate N terminus nor to each other (NCBI/Gen- 
Bank™). The natural diversity in TBP N-terminal sequences 
between metazoan clades suggests that, in terms of accom­
plishing these general functions, this domain should exhibit 
large amino acid sequence plasticity. Conversely, we have 
found that natural selection has been particularly intolerant of 
mutations that would modify the amino acid sequence of TBP N 
terminus in vertebrates.2 Thus, we suspected that, whether or 
not this domain participates in any fundamental cellular func­
tions, the vertebrate TBP N terminus must have a truly ver­
tebrate-specific activity, and it is this function that has been so 
highly conserved by natural selection in vertebrates. In design­
ing the TBP-AN mutation, we hypothesized that this function 
would be involved in a specific gene regulation process. Con­
sistent with this, we have found that mice homozygous for this 
mutation suffer from a highly specific defect that compromises 
a j32-microglobulin-dependent component of the interaction be­
tween the placenta of the developing fetus and the mother’s 
immune system (11).
In conclusion, we report that removing the TBP N terminus 
is inconsequential for general physiological properties of mouse 
fibroblasts. As such, it is unlikely that this mutation, alone, 
compromises any vital basal cellular functions in vivo, leading 



























lethally sick cells. Rather, we posit that all activities of this 
polypeptide domain likely fall within two classes. Thus, all TBP 
N terminus-dependent functions must be either functionally 
redundant components of robust systems or they will be func­
tionally restricted activities that are not manifested in primary 
embryonic fibroblast cultures.
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